{
  "Variants Include": [
    {
      "Gene": "PRKN",
      "variants": [
        {
          "HGVS": "NM_018643.7:c.289C>G",
          "cDNA Change": {
            "transcript": "NM_018643.7",
            "ref": "C",
            "alt": "G",
            "position": "289"
          },
          "Protein Change": {
            "ref": "Cys",
            "alt": "Gly",
            "position": "289"
          },
          "Description in input context": "c.289C>G (p.Cys289Gly)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0100576"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell culture and treatment with CMC",
      "Material used": {
        "Material Source": "Human neuroblastoma cell line SH-SY5Y",
        "Material Name": "SH-SY5Y cells",
        "Description": "Cells were treated with carbonyl cyanide m-chloramphenicol carboxylate (CCMC) to induce mitochondrial depolarization."
      },
      "Readout type": "Protein localization and expression",
      "Readout description": [
        {
          "Variant": "NM_018643.7:c.289C>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "misfolding and aggregation",
          "Result Description": "Mitophagy was impaired in cells expressing Parkin C289G mutant, as evidenced by reduced LC3B-II formation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated at least three times to ensure reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "No explicit mention",
        "Description": "Not detailed in the provided text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type Parkin was used to confirm proper mitophagy signaling."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-transfected cells were used as controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not explicitly detailed in the provided text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal mitophagy signaling would involve proper LC3B-II formation post-CCMC treatment.",
        "Source": "Literature interpretation"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Impaired mitophagy is indicated by reduced or absent LC3B-II formation and increased levels of cytosolic LC3B-I.",
        "Source": "Literature interpretation"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "These methods are standard for studying mitochondrial dynamics and autophagy in Parkinson's disease models."
      }
    },
    {
      "Assay Method": "Co-immunoprecipitation (Co-IP)",
      "Material used": {
        "Material Source": "SH-SY5Y cells transfected with Parkin mutants",
        "Material Name": "Parkin C289G mutant and HSJ1a overexpressing cells",
        "Description": "Used to assess interaction between Parkin mutants and chaperone proteins."
      },
      "Readout type": "Protein-protein interaction",
      "Readout description": [
        {
          "Variant": "NM_018643.7:c.289C>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced interaction with chaperones",
          "Result Description": "The C289G mutant showed reduced co-immunoprecipitation with HSJ1a compared to wild-type Parkin."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated multiple times for consistency."
      },
      "Technical replicates": {
        "Technical replicates": "No explicit mention",
        "Description": "Not detailed in the provided text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "WT Parkin interaction with chaperones was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells transfected without Parkin were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not explicitly detailed in the provided text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal interaction would involve significant co-IP signal compared to background.",
        "Source": "Literature interpretation"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal interaction is indicated by significantly reduced co-IP signal.",
        "Source": "Literature interpretation"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Co-IP is a standard method for studying protein-protein interactions in cellular models of disease."
      }
    },
    {
      "Assay Method": "Immunofluorescence and confocal microscopy",
      "Material used": {
        "Material Source": "SH-SY5Y cells treated with CMC",
        "Material Name": "Cells expressing LC3B-GFP or Parkin mutants",
        "Description": "Used to visualize mitochondrial depolarization and colocalization of LC3B with mitochondria."
      },
      "Readout type": "Imaging-based localization",
      "Readout description": [
        {
          "Variant": "NM_018643.7:c.289C>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "impaired colocalization of LC3B with mitochondria",
          "Result Description": "The C289G mutant showed reduced colocalization of LC3B with mitochondria compared to wild-type Parkin."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated multiple times for consistency."
      },
      "Technical replicates": {
        "Technical replicates": "No explicit mention",
        "Description": "Not detailed in the provided text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "WT Parkin and LC3B-GFP colocalization under normal conditions was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells without Parkin or GFP were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not explicitly detailed in the provided text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal colocalization would involve significant overlap between LC3B-GFP and mitochondrial markers.",
        "Source": "Literature interpretation"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal colocalization is indicated by reduced or absent overlap.",
        "Source": "Literature interpretation"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Immunofluorescence and confocal microscopy are standard techniques for studying subcellular localization in disease models."
      }
    }
  ]
}